Table 1.
Baseline characteristics of patients by registry.
| Category | Denmark | Sweden | OFSEP | Italy | MSBase | Total | |
|---|---|---|---|---|---|---|---|
| Patient characteristics * | |||||||
| Patient count - n | 7,990 | 15,983 | 24,616 | 26,985 | 34,752 | 110,326 | |
| Sex - n (%) | Female | 5,485 (68.7) | 11,245 (70.4) | 18,333 (74.5) | 18,315 (67.9) | 24,891 (71.6) | 78,269 (70.9) |
| Male | 2,505 (31.4) | 4,738 (29.6) | 6,283 (25.5) | 8,670 (32.1) | 9,861 (28.4) | 32,057 (29.1) | |
| Age at MS onset (years) - mean (SD) | 32.8 (9.9) | 34.4 (12.8) | 31.1 (9.5) | 29.6 (9.7) | 30.5 (9.9) | 30.9 (10.3) | |
| Age at first DMT (years) - mean (SD) | 38.3 (12.8) | 40.7 (12.4) | 36.3 (10.3) | 35.8 (10.7) | 35.5 (10.7) | 36.6 (11.0) | |
| Treatment characteristics | |||||||
| Treatment episodes - n | 14,252 | 38,229 | 65,535 | 79,816 | 71,990 | 269,822 | |
| Discontinuations – n (%) | 8,936 (62.7) | 24,704 (64.6) | 45,966 (70.1) | 59,590 (74.7) | 44,817 (62.3) | 184,013 (68.2) | |
| Treatment duration (years) – mean (SD) | 2.82 (2.38) | 2.31 (2.24) | 2.18 (2.18) | 2.06 (2.12) | 2.29 (2.20) | 2.23 (2.20) | |
*Count of individual patients contributing at least 1 treatment episode to the analysis.